What's new

[PIO] Announcement by the Ministry of Health on Cabinet decisions on the use of updated, adapted vaccines against COVID-19

30046.jpg





The Council of Ministers today approved the Ministry of Health's proposal to provide booster doses of updated, adapted COVID-19 vaccines. The Ministry's recommendation follows a study of new recommendations from the European Medicines Agency (EMA), ECDC, World Health Organization and pharmaceutical companies regarding updated, adapted vaccines evaluated by the Ministry's National Vaccine Advisory Committee on Thursday, September 8, 2022.

Specifically, the Cabinet approved:

a) booster/3rd dose to persons 12 years of age and older, provided that a period of five (5) months has elapsed since the receipt of the 2nd dose. It is understood that the validity of the European Digital Certificate (SafePass) will not be affected in case of non-receipt of a booster/3rd dose.

b) 2nd booster/4th dose:

  1. In persons over 30 years of age,
  2. In persons living or working in nursing homes and shelters regardless of age,
  3. In health care professionals regardless of age,
  4. In pregnant women regardless of age, In persons over 12 years of age with:
    1. diabetes mellitus,
    2. severe obesity: BMI ≥40 or ≥35 with metabolic syndrome,
    3. severe chronic cardiovascular disease,
    4. severe chronic kidney disease,
    5. severe chronic liver disease,
    6. severe chronic neurological disease,
    7. haemoglobinopathies,
    8. in immunodeficient and immunosuppressed patients such as:

- on active treatment for solid tumours and haematological malignancies,

- with a history of solid organ transplantation receiving immunosuppressive therapy,

- with a history of primary hematopoietic organ transplantation receiving immunosuppressive therapy,

- with hereditary immunodeficiency,

- with HIV infection/AIDS,

- on immunosuppressive therapy including biological agents,

- with renal failure undergoing dialysis or peritoneal dialysis,

- with regard to cortisone intake,

- with regard to cortisone intake refers to subjects who have received or are receiving a total dose of '10 mg prednisone/day (=8 mg methylprednisolone) for one (1) month in the last six months,

provided that a period of five (5) months has elapsed since receiving the booster/3rd dose. It is understood that the validity of the European Digital Certificate (SafePass) will not be affected in case of non-receipt of the booster/4th dose.

More information on the availability of the updated, adapted vaccines will be announced in the coming days.

(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO

Source

 
Back
Top